Autolus publishes CAR T module, updates AUTO1/22 data in pediatric ALL
Autolus published preclinical data on a new T cell module to improve efficacy against solid tumours and reported an incremental update for the CARPALL study with AUTO1/22 (CD19/CD22 CAR T) in pediatric acute lymphoblastic leukaemia (ALL). The clean safety and excellent CR rates were reiterated, and
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.